Document text
Principal Investigator: Xuyi Yue
Organization: NEMOURS CHILDREN'S HOSPITAL, DELAWARE
Fiscal Year: 2022
Award: $177,500
Funding agency: National Institute of Biomedical Imaging and Bioengineering
PROJECT SUMMARY
The coronavirus disease2019 (COVID-19) pandemic is an ongoing global pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). New COVID-19 cases and COVID-19 related deaths
continue to rise rapidly and no effective drugs or vaccines are currently available. The functional entry receptor
utilized by SARS-CoV-2 is Angiotensin-Converting Enzyme 2 (ACE2). SARS-CoV-2 binds to ACE2 in the lower
respiratory tracts of infected patients to gain entry into lung cells, leading to viral pneumonia and potentially fatal
respiratory failure. Many studies have shown that patients with comorbid conditions including respiratory disease,
cardiovascular disease, kidney disease, diabetes, and hypertension have much higher mortality rates. ACE
inhibitors and angiotensin receptor blockers (ARB) are frequently used to treat these pre-existing conditions and
the question remains whether such treatment may affect the outcome in COVID-19 patients due to the inhibitors'
effects on ACE2 expression. Many experts are concerned that those inhibitors for the treatment of patients with
such underlying conditions may exacerbate COVID-19 symptoms and lead to higher mortality rates. Currently
the precise relationship between ACE2 levels and severity of the infection is not well understood, due to a lack
of understanding of whole-body ACE2 expression levels and distribution. Here we propose to design and
synthesize a series of new fluorine-18 labeled positron emission tomography (PET) tracers targeting ACE2. The
radiotracers will be evaluated in vitro for cellular binding affinity, selectivity, and metabolic stability. The most
promising radiotracer will be moved to in vivo studies including whole body biodistribution with dynamic PET
imaging, and correlation with biomolecular analysis in mice that express human ACE2. The PET imaging
modality will provide a powerful tool for noninvasive and quantitative evaluation of ACE2 levels in living subjects.
Furthermore, the radiotracer may help to unveil the precise relationship between ACE2 levels and severity of
COVID-19.
Terms: <0-11 years old><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><21+ years old><ACE Inhibitors><ACE2><Adult><Adult Human><Affect><Affinity><AngII><Angiotensin I><Angiotensin I-Converting Enzyme Inhibitors><Angiotensin II><Angiotensin Receptor><Angiotensin-Converting Enzyme Antagonists><Angiotensin-Converting Enzyme Inhibitors><Animal Model><Animal Models and Related Studies><Assay><BP homeostasis><BP regulation><Binding><Bioassay><Biodistribution><Biologic Assays><Biological Assay><Blood Plasma><COVID crisis><COVID disease severity><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID severity><COVID-19><COVID-19 associated death><COVID-19 associated fatality><COVID-19 associated mortality><COVID-19 crisis><COVID-19 death><COVID-19 detection><COVID-19 disease severity><COVID-19 epidemic><COVID-19 fatality><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 induced death><COVID-19 induced fatality><COVID-19 induced mortality><COVID-19 infected patient><COVID-19 infection><COVID-19 mortality><COVID-19 pandemic><COVID-19 patient><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 related death><COVID-19 related fatality><COVID-19 related mortality><COVID-19 severity><COVID-19 therapeutics><COVID-19 therapy><COVID-19 treatment><COVID-19 virus><COVID19><COVID19 detection><COVID19 associated death><COVID19 associated fatality><COVID19 associated mortality><COVID19 crisis><COVID19 death><COVID19 disease severity><COVID19 epidemic><COVID19 fatality><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 induced death><COVID19 induced fatality><COVID19 induced mortality><COVID19 infection><COVID19 mortality><COVID19 pandemic><COVID19 patient><COVID19 positive patient><COVID19 public health crisis><COVID19 related death><COVID19 related fatality><COVID19 related mortality><COVID19 severity><COVID19 therapeutics><COVID19 therapy><COVID19 treatment><COVID19 virus><CV-19><CV19><Cardiovascular Diseases><Cell Body><Cells><Child><Child Youth><Children (0-21)><CoV-2><CoV2><Coronaviridae><Coronavirus><Development><Diabetes Mellitus><Disease><Disorder><Disputes><Drugs><Equilibrium><Evaluation><Experimental Models><F element><FDG PET><Fluorine><Goals><Heart><Heart failure><Histologic><Histologically><Hormonal><Human><Hypertension><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Immune Cell Activation><Immune response><Immunological response><In Vitro><Infection><Inflammatory><KO mice><Kidney><Kidney Diseases><Kidney Urinary System><Kininase II Antagonists><Kininase II Inhibitors><Knock-out Mice><Knockout Mice><Label><Lead><Lesion><Lower respiratory tract structure><Lung><Lung Respiratory System><MLN-4760><MLN4760><Medication><Metabolic><Metallopeptidases><Metalloproteases><Metalloproteinases><Mice><Mice Mammals><Modern Man><Molecular Analysis><Molecular Interaction><Murine><Mus><Nephropathy><Null Mouse><Organ><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Patients><Pb element><Permeability><Pharmaceutic Preparations><Pharmaceutical Preparations><Phase><Physiology><Plasma><Plasma Serum><Play><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Property><Quantitative Evaluations><Rad.-PET><Receptor Protein><Renal Disease><Renin-Angiotensin System><Reporting><Research><Respiratory Disease><Respiratory Failure><Respiratory System Disease><Respiratory System Disorder><Reticuloendothelial System, Serum, Plasma><Role><SARS><SARS corona virus 2><SARS coronavirus disease><SARS-CO-V2><SARS-COVID-2><SARS-CoV disease><SARS-CoV-2><SARS-CoV-2 associated death><SARS-CoV-2 associated fatality><SARS-CoV-2 associated mortality><SARS-CoV-2 death><SARS-CoV-2 detection><SARS-CoV-2 disease severity><SARS-CoV-2 epidemic><SARS-CoV-2 fatality><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 induced death><SARS-CoV-2 induced fatality><SARS-CoV-2 induced mortality><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 mortality><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 related death><SARS-CoV-2 related fatality><SARS-CoV-2 related mortality><SARS-CoV-2 severity><SARS-CoV-2 therapeutics><SARS-CoV-2 therapy><SARS-CoV-2 treatment><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 infection><SARS-CoV2 pandemic><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 therapeutics><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scanning><Scientist><Series><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome coronavirus disease><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 therapeutics><Severe acute respiratory syndrome related corona virus 2><Severities><Symptoms><Testing><Time><Tracer><Transgenic Mice><Vaccines><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Viral Pneumonia><Wild Type Mouse><Wuhan coronavirus><adulthood><angiotensin converting enzyme 2><angiotensin converting enzyme II><balance><balance function><base><blood pressure homeostasis><blood pressure regulation><cardiac failure><cardiovascular disorder><child patients><co-morbid><co-morbidity><comorbidity><corona virus><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 associated death><coronavirus disease 2019 associated fatality><coronavirus disease 2019 associated mortality><coronavirus disease 2019 crisis><coronavirus disease 2019 death><coronavirus disease 2019 detection><coronavirus disease 2019 disease severity><coronavirus disease 2019 epidemic><coronavirus disease 2019 fatality><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 induced death><coronavirus disease 2019 induced fatality><coronavirus disease 2019 induced mortality><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 mortality><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 related death><coronavirus disease 2019 related fatality><coronavirus disease 2019 related mortality><coronavirus disease 2019 severity><coronavirus disease 2019 therapeutics><coronavirus disease 2019 therapy><coronavirus disease 2019 treatment><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease severity><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 mortality><coronavirus disease-19 pandemic><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus infectious disease-19><coronavirus patient><death due to COVID-19><death due to COVID19><death due to SARS-CoV-2><death due to coronavirus disease 2019><death due to severe acute respiratory syndrome coronavirus 2><death in COVID><death in COVID-19><death in SARS-CoV-2><death in coronavirus disease><death in coronavirus disease 2019><death in severe acute respiratory syndrome coronavirus 2><design><designing><detect COVID-19><detect COVID19><detect SARS-CoV-2><detect severe acute respiratory syndrome coronavirus 2><developmental><diabetes><drug/agent><fatality due to COVID-19><fatality due to COVID19><fatality due to SARS-CoV-2><fatality due to coronavirus disease 2019><fatality due to severe acute respiratory syndrome coronavirus 2><fluorodeoxyglucose PET><fluorodeoxyglucose positron emission tomography><hCoV19><heavy metal Pb><heavy metal lead><high blood pressure><host response><human subject><hyperpiesia><hyperpiesis><hypertension treatment><hypertensive disease><hypertensive disorder><image-based method><imaging><imaging method><imaging modality><imaging probe><immune activation><immune system response><immunoresponse><in vivo><in vivo evaluation><in vivo testing><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><inhibitor><kidney disorder><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><lower respiratory tract><lung failure><membrane activity><metabolic rate><model of animal><model organism><molecular biomarker><molecular marker><mortality><mortality due to COVID-19><mortality due to COVID19><mortality due to SARS-CoV-2><mortality due to coronavirus disease 2019><mortality due to severe acute respiratory syndrome coronavirus 2><mouse model><murine model><nCoV2><novel><pandemic><pandemic disease><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><pediatric patients><pneumocyte><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><protective effect><pulmonary><pulmonary failure><radiolabel><radiotracer><receptor><receptor expression><regulate BP><regulate blood pressure><renal><renal disorder><response to therapy><response to treatment><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 associated death><severe acute respiratory syndrome coronavirus 2 associated fatality><severe acute respiratory syndrome coronavirus 2 associated mortality><severe acute respiratory syndrome coronavirus 2 death><severe acute respiratory syndrome coronavirus 2 detection><severe acute respiratory syndrome coronavirus 2 disease severity><severe acute respiratory syndrome coronavirus 2 fatality><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 induced death><severe acute respiratory syndrome coronavirus 2 induced fatality><severe acute respiratory syndrome coronavirus 2 induced mortality><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 mortality><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 related death><severe acute respiratory syndrome coronavirus 2 related fatality><severe acute respiratory syndrome coronavirus 2 related mortality><severe acute respiratory syndrome coronavirus 2 severity><severe acute respiratory syndrome coronavirus 2 therapy><severe acute respiratory syndrome coronavirus 2 treatment><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><social role><therapeutic response><therapeutics against COVID-19><therapeutics against COVID19><therapeutics against SARS-CoV-2><therapeutics against SARS-coronavirus-2><therapeutics against Severe acute respiratory syndrome coronavirus 2><therapeutics against coronavirus disease 2019><therapeutics for novel coronavirus><therapy response><tool><treat COVID-19><treat COVID19><treat SARS-CoV-2><treat coronavirus disease 2019><treat severe acute respiratory syndrome coronavirus 2><treatment response><uptake><wildtype mouse><youngster>